Parenteral formula sales will expand through 2036, with amino acids holding a 33.8% share of the nutrient type segment. Malnutrition leads the indication segment with a 28.9% share. The market is set to reach USD 7.6 billion by 2026-end and is projected to reach USD 12.9 billion by 2036.